Inna Tulaeva

548 total citations
9 papers, 171 citations indexed

About

Inna Tulaeva is a scholar working on Immunology and Allergy, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Inna Tulaeva has authored 9 papers receiving a total of 171 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology and Allergy, 3 papers in Infectious Diseases and 2 papers in Molecular Biology. Recurrent topics in Inna Tulaeva's work include Food Allergy and Anaphylaxis Research (4 papers), Allergic Rhinitis and Sensitization (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Inna Tulaeva is often cited by papers focused on Food Allergy and Anaphylaxis Research (4 papers), Allergic Rhinitis and Sensitization (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Inna Tulaeva collaborates with scholars based in Austria, Russia and Sweden. Inna Tulaeva's co-authors include Rudolf Valenta, А. В. Караулов, Musa Khaitov, Winfried F. Pickl, Antonina Karsonova, Ksenja Riabova, Margarete Focke‐Tejkl, D.А. Kudlаy, Sabine Flicker and Yulia Dorofeeva and has published in prestigious journals such as Frontiers in Immunology, Allergy and EBioMedicine.

In The Last Decade

Inna Tulaeva

8 papers receiving 168 citations

Peers

Inna Tulaeva

IA

PHYSI

DERMA

ID

IMMUN

Carroll G. Bull United Kingdom

Eva Wollmann Austria

Chiara Tontini United Kingdom

Brenda Simpson United States

Charuta Agashe United States

Renáta Kiss Austria

Daniel Carbajo Singapore

P Müller Germany

Martti Antila Brazil

Allyssa Phelps Canada

Carroll G. Bull United Kingdom

Inna Tulaeva

115 ×1.0

IA

101 ×1.6

PHYSI

45 ×1.0

DERMA

12 ×0.5

ID

48 ×2.4

IMMUN

Citations per year, relative to Inna Tulaeva Inna Tulaeva (= 1×) peers Carroll G. Bull

Countries citing papers authored by Inna Tulaeva

Since Specialization

Citations

This map shows the geographic impact of Inna Tulaeva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inna Tulaeva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inna Tulaeva more than expected).

Fields of papers citing papers by Inna Tulaeva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inna Tulaeva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inna Tulaeva. The network helps show where Inna Tulaeva may publish in the future.

Co-authorship network of co-authors of Inna Tulaeva

This figure shows the co-authorship network connecting the top 25 collaborators of Inna Tulaeva. A scholar is included among the top collaborators of Inna Tulaeva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inna Tulaeva. Inna Tulaeva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Curin, Mirela, Margarete Focke‐Tejkl, Pia Gattinger, et al.. (2025). Recombinant Hypoallergenic Cat Allergy Vaccines. Allergy. 80(9). 2622–2635. 2 indexed citations

2.

Kratzer, Bernhard, Pia Gattinger, Doris Trapin, et al.. (2024). Flow Cytometry-Based Measurement of Antibodies Specific for Cell Surface-Expressed Folded SARS-CoV-2 Receptor-Binding Domains. Vaccines. 12(4). 377–377. 1 indexed citations

3.

Tulaeva, Inna, Nora Goldmann, Carolin Cornelius, et al.. (2024). The PreS-Based Recombinant Vaccine VVX001 Induces Hepatitis B Virus Neutralizing Antibodies in a Low-Responder to HBsAg-Based HBV Vaccines. Vaccines. 12(10). 1123–1123.

4.

Kratzer, Bernhard, Pia Gattinger, Doris Trapin, et al.. (2024). Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19. Allergy. 79(9). 2482–2501. 14 indexed citations

5.

Tulaeva, Inna, Ksenja Riabova, Antonina Karsonova, et al.. (2023). Albumins represent highly cross-reactive animal allergens. Frontiers in Immunology. 14. 1241518–1241518. 13 indexed citations

6.

Gattinger, Pia, Bernhard Kratzer, Inna Tulaeva, et al.. (2022). Vaccine based on folded receptor binding domain‐PreS fusion protein with potential to induce sterilizing immunity to SARS‐CoV‐2 variants. Allergy. 77(8). 2431–2445. 18 indexed citations

7.

Tulaeva, Inna, Bernhard Kratzer, Raffaela Campana, et al.. (2020). Preventive Allergen-Specific Vaccination Against Allergy: Mission Possible?. Frontiers in Immunology. 11. 1368–1368. 26 indexed citations

8.

Tulaeva, Inna, Carolin Cornelius, Petra Zieglmayer, et al.. (2020). Quantification, epitope mapping and genotype cross-reactivity of hepatitis B preS-specific antibodies in subjects vaccinated with different dosage regimens of BM32. EBioMedicine. 59. 102953–102953. 11 indexed citations

9.

Dorofeeva, Yulia, I.P. Shilovskiy, Inna Tulaeva, et al.. (2020). Past, present, and future of allergen immunotherapy vaccines. Allergy. 76(1). 131–149. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact